No black box warning on record for Tzield

As of the latest FDA labeling reviewed, Tzield (TEPLIZUMAB-MZWV) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tzield medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Cytokine Release Syndrome (CRS): Premedicate, monitor liver enzymes, discontinue in those that develop elevated ALT or AST more than 5 times the upper limit of normal, and if severe CRS develops consider temporarily pausing dosing ( 5.2 ). Serious Infections: Use of TZIELD is not recommended in patients with active serious infection or chronic infection. Monitor for sign

No black box warning on record for Tzield

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Cytokine Release Syndrome (CRS): Premedicate, monitor liver enzymes, discontinue in those that develop elevated ALT or AST more than 5 times the upper limit of normal, and if severe CRS develops consider temporarily pausing dosing ( 5.2 ). Serious Infections: Use of TZIELD is not recommended in patients with active serious infection or chronic infection. Monitor for sign

Tzield Black Box Warning

No black box warning on record for Tzield

Other warnings & precautions

Tzield Black Box Warning

No black box warning on record for Tzield

Other warnings & precautions